Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000163758 | SCV000214335 | likely benign | Hereditary cancer-predisposing syndrome | 2014-10-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001085061 | SCV000259889 | likely benign | Ataxia-telangiectasia syndrome | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000163758 | SCV000682211 | likely benign | Hereditary cancer-predisposing syndrome | 2017-02-18 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000761806 | SCV000892005 | uncertain significance | not provided | 2018-06-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000761806 | SCV001944106 | benign | not provided | 2015-09-28 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000163758 | SCV002534845 | likely benign | Hereditary cancer-predisposing syndrome | 2021-04-30 | criteria provided, single submitter | curation | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002265641 | SCV002548091 | likely benign | not specified | 2022-05-05 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003492680 | SCV004240724 | likely benign | Breast and/or ovarian cancer | 2022-07-20 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004589727 | SCV005085781 | benign | Familial cancer of breast | 2024-05-20 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Prevention |
RCV004551410 | SCV004759858 | likely benign | ATM-related disorder | 2019-11-01 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |